Biologic Products in Nerve Repair Market Size(US$)

CAGR 2026-2032
21.0%
Market Size,2032
USD 581
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Biologic Products in Nerve Repair was estimated to be worth US$ 156 million in 2025 and is projected to reach US$ 581 million, growing at a CAGR of 21.0% from 2026 to 2032.
Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage or discontinuity of this type generally requires a surgical repair.
The North American market for Biologic Products in Nerve Repair was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Biologic Products in Nerve Repair was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Biologic Products in Nerve Repair was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Biologic Products in Nerve Repair market include Axogen, Integra, Synovis, Collagen Matrix, Polyganics, Checkpoint Surgical, Neurotex, Toyobo, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Biologic Products in Nerve Repair, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Biologic Products in Nerve Repair market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Biologic Products in Nerve Repair.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Biologic Products in Nerve Repair manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Biologic Products in Nerve Repair sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Biologic Products in Nerve Repair sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Market Overview
1.1 Biologic Products in Nerve Repair Product Introduction
1.2 Global Biologic Products in Nerve Repair Market Size Forecast
1.2.1 Global Biologic Products in Nerve Repair Sales Value (2021–2032)
1.2.2 Global Biologic Products in Nerve Repair Sales Volume (2021–2032)
1.2.3 Global Biologic Products in Nerve Repair Sales Price (2021–2032)
1.3 Biologic Products in Nerve Repair Market Trends & Drivers
1.3.1 Biologic Products in Nerve Repair Industry Trends
1.3.2 Biologic Products in Nerve Repair Market Drivers & Opportunities
1.3.3 Biologic Products in Nerve Repair Market Challenges
1.3.4 Biologic Products in Nerve Repair Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biologic Products in Nerve Repair Players Revenue Ranking (2025)
2.2 Global Biologic Products in Nerve Repair Revenue by Company (2021–2026)
2.3 Global Biologic Products in Nerve Repair Sales Volume Ranking of Players (2025)
2.4 Global Biologic Products in Nerve Repair Sales Volume by Company (2021–2026)
2.5 Global Biologic Products in Nerve Repair Average Price by Company (2021–2026)
2.6 Key Manufacturers Biologic Products in Nerve Repair Manufacturing Base and Headquarters
2.7 Key Manufacturers Biologic Products in Nerve Repair Product Offerings
2.8 Key Manufacturers Start of Mass Production of Biologic Products in Nerve Repair
2.9 Biologic Products in Nerve Repair Market Competitive Analysis
2.9.1 Biologic Products in Nerve Repair Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Biologic Products in Nerve Repair Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Biologic Products in Nerve Repair revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Biologic Products in Nerve Repair Market Classification
3.1 Introduction by Type
3.1.1 Nerve Conduit
3.1.2 Nerve Wrap
3.1.3 Nerve Graft
3.1.4 Others
3.1.5 Global Biologic Products in Nerve Repair Sales Value by Type
3.1.5.1 Global Biologic Products in Nerve Repair Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Biologic Products in Nerve Repair Sales Value, by Type (2021–2032)
3.1.5.3 Global Biologic Products in Nerve Repair Sales Value, by Type (%), 2021–2032
3.1.6 Global Biologic Products in Nerve Repair Sales Volume by Type
3.1.6.1 Global Biologic Products in Nerve Repair Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Biologic Products in Nerve Repair Sales Volume, by Type (2021–2032)
3.1.6.3 Global Biologic Products in Nerve Repair Sales Volume, by Type (%), 2021–2032
3.1.7 Global Biologic Products in Nerve Repair Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Direct Nerve Repair
4.1.2 Nerve Grafting
4.2 Global Biologic Products in Nerve Repair Sales Value by Application
4.2.1 Global Biologic Products in Nerve Repair Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Biologic Products in Nerve Repair Sales Value, by Application (2021–2032)
4.2.3 Global Biologic Products in Nerve Repair Sales Value, by Application (%), 2021–2032
4.3 Global Biologic Products in Nerve Repair Sales Volume by Application
4.3.1 Global Biologic Products in Nerve Repair Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Biologic Products in Nerve Repair Sales Volume, by Application (2021–2032)
4.3.3 Global Biologic Products in Nerve Repair Sales Volume, by Application (%), 2021–2032
4.4 Global Biologic Products in Nerve Repair Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Biologic Products in Nerve Repair Sales Value by Region
5.1.1 Global Biologic Products in Nerve Repair Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Biologic Products in Nerve Repair Sales Value by Region (2021–2026)
5.1.3 Global Biologic Products in Nerve Repair Sales Value by Region (2027–2032)
5.1.4 Global Biologic Products in Nerve Repair Sales Value by Region (%), 2021–2032
5.2 Global Biologic Products in Nerve Repair Sales Volume by Region
5.2.1 Global Biologic Products in Nerve Repair Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Biologic Products in Nerve Repair Sales Volume by Region (2021–2026)
5.2.3 Global Biologic Products in Nerve Repair Sales Volume by Region (2027–2032)
5.2.4 Global Biologic Products in Nerve Repair Sales Volume by Region (%), 2021–2032
5.3 Global Biologic Products in Nerve Repair Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Biologic Products in Nerve Repair Sales Value, 2021–2032
5.4.2 North America Biologic Products in Nerve Repair Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Biologic Products in Nerve Repair Sales Value, 2021–2032
5.5.2 Europe Biologic Products in Nerve Repair Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Biologic Products in Nerve Repair Sales Value, 2021–2032
5.6.2 Asia Pacific Biologic Products in Nerve Repair Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Biologic Products in Nerve Repair Sales Value, 2021–2032
5.7.2 South America Biologic Products in Nerve Repair Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Biologic Products in Nerve Repair Sales Value, 2021–2032
5.8.2 Middle East & Africa Biologic Products in Nerve Repair Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biologic Products in Nerve Repair Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Biologic Products in Nerve Repair Sales Value and Sales Volume
6.2.1 Key Countries/Regions Biologic Products in Nerve Repair Sales Value, 2021–2032
6.2.2 Key Countries/Regions Biologic Products in Nerve Repair Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Biologic Products in Nerve Repair Sales Value, 2021–2032
6.3.2 United States Biologic Products in Nerve Repair Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Biologic Products in Nerve Repair Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Biologic Products in Nerve Repair Sales Value, 2021–2032
6.4.2 Europe Biologic Products in Nerve Repair Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Biologic Products in Nerve Repair Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Biologic Products in Nerve Repair Sales Value, 2021–2032
6.5.2 China Biologic Products in Nerve Repair Sales Value by Type (%), 2025 vs 2032
6.5.3 China Biologic Products in Nerve Repair Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Biologic Products in Nerve Repair Sales Value, 2021–2032
6.6.2 Japan Biologic Products in Nerve Repair Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Biologic Products in Nerve Repair Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Biologic Products in Nerve Repair Sales Value, 2021–2032
6.7.2 South Korea Biologic Products in Nerve Repair Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Biologic Products in Nerve Repair Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Biologic Products in Nerve Repair Sales Value, 2021–2032
6.8.2 Southeast Asia Biologic Products in Nerve Repair Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Biologic Products in Nerve Repair Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Biologic Products in Nerve Repair Sales Value, 2021–2032
6.9.2 India Biologic Products in Nerve Repair Sales Value by Type (%), 2025 vs 2032
6.9.3 India Biologic Products in Nerve Repair Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Axogen
7.1.1 Axogen Company Information
7.1.2 Axogen Introduction and Business Overview
7.1.3 Axogen Biologic Products in Nerve Repair Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Axogen Biologic Products in Nerve Repair Product Offerings
7.1.5 Axogen Recent Developments
7.2 Integra
7.2.1 Integra Company Information
7.2.2 Integra Introduction and Business Overview
7.2.3 Integra Biologic Products in Nerve Repair Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Integra Biologic Products in Nerve Repair Product Offerings
7.2.5 Integra Recent Developments
7.3 Synovis
7.3.1 Synovis Company Information
7.3.2 Synovis Introduction and Business Overview
7.3.3 Synovis Biologic Products in Nerve Repair Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Synovis Biologic Products in Nerve Repair Product Offerings
7.3.5 Synovis Recent Developments
7.4 Collagen Matrix
7.4.1 Collagen Matrix Company Information
7.4.2 Collagen Matrix Introduction and Business Overview
7.4.3 Collagen Matrix Biologic Products in Nerve Repair Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Collagen Matrix Biologic Products in Nerve Repair Product Offerings
7.4.5 Collagen Matrix Recent Developments
7.5 Polyganics
7.5.1 Polyganics Company Information
7.5.2 Polyganics Introduction and Business Overview
7.5.3 Polyganics Biologic Products in Nerve Repair Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Polyganics Biologic Products in Nerve Repair Product Offerings
7.5.5 Polyganics Recent Developments
7.6 Checkpoint Surgical
7.6.1 Checkpoint Surgical Company Information
7.6.2 Checkpoint Surgical Introduction and Business Overview
7.6.3 Checkpoint Surgical Biologic Products in Nerve Repair Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Checkpoint Surgical Biologic Products in Nerve Repair Product Offerings
7.6.5 Checkpoint Surgical Recent Developments
7.7 Neurotex
7.7.1 Neurotex Company Information
7.7.2 Neurotex Introduction and Business Overview
7.7.3 Neurotex Biologic Products in Nerve Repair Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Neurotex Biologic Products in Nerve Repair Product Offerings
7.7.5 Neurotex Recent Developments
7.8 Toyobo
7.8.1 Toyobo Company Information
7.8.2 Toyobo Introduction and Business Overview
7.8.3 Toyobo Biologic Products in Nerve Repair Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Toyobo Biologic Products in Nerve Repair Product Offerings
7.8.5 Toyobo Recent Developments
8 Industry Chain Analysis
8.1 Biologic Products in Nerve Repair Industrial Chain
8.2 Biologic Products in Nerve Repair Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Biologic Products in Nerve Repair Sales Model
8.5.2 Sales Channels
8.5.3 Biologic Products in Nerve Repair Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
List of Figures
Related Reports
Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage or discontinuity of this type generally requires a surgical repair.
Published Date: 2024-01-24
Pages: 92
USD 3950.00
(Single User License)
Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage or discontinuity of this type generally requires a surgical repair.
Published Date: 2024-01-31
Pages: 80
USD 2900.00
(Single User License)
Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage or discontinuity of this type generally requires a surgical repair.
Published Date: 2024-04-26
Pages: 87
USD 4900.00
(Single User License)
The global market for Biologic Products in Nerve Repair was valued at US$ 131 million in the year 2024 and is projected to reach a revised size of US$ 489 million by 2031, growing at a CAGR of 21.0% during the forecast period.
Published Date: 2025-02-25
Pages: 84
USD 2900.00
(Single User License)
The global market for Biologic Products in Nerve Repair was estimated to be worth US$ 131 million in 2024 and is forecast to a readjusted size of US$ 489 million by 2031 with a CAGR of 21.0% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 92
USD 3950.00
(Single User License)
The global Biologic Products in Nerve Repair market size was US$ 131 million in 2024 and is forecast to a readjusted size of US$ 489 million by 2031 with a CAGR of 21.0% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 77
USD 4250.00
(Single User License)
The global Biologic Products in Nerve Repair market is projected to grow from US$ 131 million in 2024 to US$ 489 million by 2031, at a CAGR of 21.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 145
USD 4900.00
(Single User License)
The global Biologic Products in Nerve Repair market was valued at US$ 156 million in 2025 and is anticipated to reach US$ 581 million by 2032, at a CAGR of 21.0% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 114
USD 2900.00
(Single User License)
Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage or discontinuity of this type generally requires a surgical repair.
Published: 2024-01-24
Pages: 92
Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage or discontinuity of this type generally requires a surgical repair.
Published: 2024-01-31
Pages: 80
Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage or discontinuity of this type generally requires a surgical repair.
Published: 2024-04-26
Pages: 87
The global market for Biologic Products in Nerve Repair was valued at US$ 131 million in the year 2024 and is projected to reach a revised size of US$ 489 million by 2031, growing at a CAGR of 21.0% during the forecast period.
Published: 2025-02-25
Pages: 84
The global market for Biologic Products in Nerve Repair was estimated to be worth US$ 131 million in 2024 and is forecast to a readjusted size of US$ 489 million by 2031 with a CAGR of 21.0% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 92
The global Biologic Products in Nerve Repair market size was US$ 131 million in 2024 and is forecast to a readjusted size of US$ 489 million by 2031 with a CAGR of 21.0% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 77
The global Biologic Products in Nerve Repair market is projected to grow from US$ 131 million in 2024 to US$ 489 million by 2031, at a CAGR of 21.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 145
The global Biologic Products in Nerve Repair market was valued at US$ 156 million in 2025 and is anticipated to reach US$ 581 million by 2032, at a CAGR of 21.0% from 2026 to 2032.
Published: 2026-04-28
Pages: 114
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research